OverviewSuggest Edit

miRagen Therapeutics is a biopharmaceutical company discovering and developing innovative microRNA (miRNA)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. The Company leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners.
TypePublic
Founded2007
HQBoulder, US
Websitemiragen.com

Latest Updates

Employees (est.) (Dec 2019)45(-41%)
Revenue (FY, 2019)$4.5 M(-46%)
Share Price (Aug 2020)$1.1 (-2%)
Cybersecurity ratingAMore

Key People/Management at miRagen Therapeutics

William S. Marshall

William S. Marshall

Board of Directors Member, CO-Founder, President and Chief Executive Officer, Miragen Therapeutics

miRagen Therapeutics Office Locations

miRagen Therapeutics has an office in Boulder
Boulder, US (HQ)
6200 Lookout Rd
Show all (1)

miRagen Therapeutics Financials and Metrics

miRagen Therapeutics Revenue

miRagen Therapeutics's revenue was reported to be $4.46 m in FY, 2019
USD

Market capitalization (12-Aug-2020)

64.0m

Closing stock price (12-Aug-2020)

1.1

Cash (30-Jun-2020)

30.6m

EV

42.2m
miRagen Therapeutics's current market capitalization is $64 m.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

4.3m2.5m3.3m4.0m8.4m4.5m

Cost of goods sold

3.2m2.5m2.5m

Gross profit

1.1m66.0k789.0k

Gross profit Margin, %

25%3%24%
Quarterly
USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

1.3m1.3m645.0k734.0k501.0k818.0k874.0k889.0k462.0k718.0k1.6m4.8m2.2m944.0k372.0k2.5m695.0k828.0k

Cost of goods sold

675.7k871.5k760.0k678.0k577.0k629.0k628.0k599.0k

Gross profit

597.8k429.5k(115.0k)56.0k(76.0k)189.0k246.0k290.0k

Gross profit Margin, %

47%33%(18%)8%(15%)23%28%33%
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

5.1m10.8m3.3m47.4m32.6m26.8m

Accounts Receivable

1.1m394.0k524.0k1.5m24.0k108.0k

Prepaid Expenses

349.0k321.0k160.0k3.0m2.9m2.8m

Inventories

179.0k187.0k64.0k
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Net Income

(7.9m)(11.3m)(12.7m)(26.5m)(32.7m)(41.9m)

Depreciation and Amortization

144.0k184.0k189.0k308.0k

Inventories

178.0k(8.0k)123.0k

Accounts Payable

383.0k633.0k2.0m(101.0k)(335.0k)525.0k
USDQ2, 2014

Financial Leverage

1.3 x
Show all financial metrics

miRagen Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

A

93/100

SecurityScorecard logo

miRagen Therapeutics Online and Social Media Presence

Embed Graph

miRagen Therapeutics News and Updates

Thinking about buying stock in New Age Beverages, Lexicon Pharmaceuticals, Miragen Therapeutics, Opko Health, or Niu Technologies?

NEW YORK, July 21, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NBEV, LXRX, MGEN, OPK, and NIU. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Virgin Galactic, Miragen Therapeutics, Nantkwest Inc, Agenus Inc, or Norwegian Cruise Line?

NEW YORK, June 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SPCE, MGEN, NK, AGEN, and NCLH. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

Thinking about buying stock in Energous Corp, Miragen Therapeutics, Hertz, Kopin Corp, or MGM Resorts?

NEW YORK, June 17, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for WATT, MGEN, HTZ, KOPN, and MGM. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link....

miRagen Therapeutics to Present a Corporate Overview at the Jefferies 2019 Global Healthcare Conference

BOULDER, Colo., May 28, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, announced today that William S. Marshall, Ph.D., President and Chief Executive Of…

miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th

BOULDER, Colo., April 25, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a conference call on Wednesday, May 8th, at 4:30 p.m. ET to discuss its financial r…

miRagen Therapeutics Announces Board of Director Evolution and Appointment of New Chairman

BOULDER, Colo., Dec. 05, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced the appointment of Jeff Hatfield, a Director since 2017, as Chairman of the Bo…
Show more

miRagen Therapeutics Frequently Asked Questions

  • When was miRagen Therapeutics founded?

    miRagen Therapeutics was founded in 2007.

  • Who are miRagen Therapeutics key executives?

    miRagen Therapeutics's key executives are William S. Marshall.

  • How many employees does miRagen Therapeutics have?

    miRagen Therapeutics has 45 employees.

  • What is miRagen Therapeutics revenue?

    Latest miRagen Therapeutics annual revenue is $4.5 m.

  • What is miRagen Therapeutics revenue per employee?

    Latest miRagen Therapeutics revenue per employee is $99.1 k.

  • Who are miRagen Therapeutics competitors?

    Competitors of miRagen Therapeutics include Kewaunee, FIRE1 and Wuxi Vision Pro.

  • Where is miRagen Therapeutics headquarters?

    miRagen Therapeutics headquarters is located at 6200 Lookout Rd, Boulder.

  • Where are miRagen Therapeutics offices?

    miRagen Therapeutics has an office in Boulder.

  • How many offices does miRagen Therapeutics have?

    miRagen Therapeutics has 1 office.